Bayer Corporation and GlaxoSmithKline

have agreed to pay settlement amounts totalling more than $344 million for their fraudulent conduct in a scheme involving the re-labeling of products to an HMO at deeply discounted prices, and then concealing and avoiding their obligation to pay millions of dollars in additional rebates to the Medicaid program. (Apr-16-03)

Legal Help

If you have a similar problem and would like to be contacted by a lawyer at no obligation, please click the link below to submit your complaint.